HeartSciences (NASDAQ:HSCS) and Bullfrog AI (NASDAQ:BFRG) Critical Analysis

Bullfrog AI (NASDAQ:BFRG) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends and risk.

Earnings & Valuation

This table compares Bullfrog AI and HeartSciences”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$60,000.00	242.58	-$6.99 million	($0.76)	-1.87
HeartSciences	N/A	N/A	-$8.77 million	($8.30)	-0.40

Bullfrog AI has higher revenue and earnings than HeartSciences. Bullfrog AI is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bullfrog AI and HeartSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-195.35%	-162.37%
HeartSciences	N/A	-383.38%	-145.28%

Institutional and Insider Ownership

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 25.2% of Bullfrog AI shares are held by insiders. Comparatively, 1.8% of HeartSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Bullfrog AI has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, indicating that its stock price is 157% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Bullfrog AI and HeartSciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1	0	0	0	1.00
HeartSciences	1	0	2	0	2.33

HeartSciences has a consensus price target of $10.50, suggesting a potential upside of 219.15%. Given HeartSciences’ stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Bullfrog AI.

Summary

HeartSciences beats Bullfrog AI on 7 of the 12 factors compared between the two stocks.

About Bullfrog AI

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.